ahlam1399
06-29-2015, 04:28 PM
UPDATE 1-Vitae-Boehringer diabetes drug fails as add-on therapy in trial
June 29 (Reuters) - Vitae Pharmaceuticals Inc said its drug to treat type 2 diabetes in overweight patients did **t meet its main goal in a mid-stage study testing it as an add-on therapy.
http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/47aa16c1/sc/14/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=SCZe3YABZNs:ft27q2XQiPc:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=SCZe3YABZNs:ft27q2XQiPc:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=SCZe3YABZNs:ft27q2XQiPc:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=SCZe3YABZNs:ft27q2XQiPc:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=SCZe3YABZNs:ft27q2XQiPc:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/SCZe3YABZNs
June 29 (Reuters) - Vitae Pharmaceuticals Inc said its drug to treat type 2 diabetes in overweight patients did **t meet its main goal in a mid-stage study testing it as an add-on therapy.
http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/47aa16c1/sc/14/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=SCZe3YABZNs:ft27q2XQiPc:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=SCZe3YABZNs:ft27q2XQiPc:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=SCZe3YABZNs:ft27q2XQiPc:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=SCZe3YABZNs:ft27q2XQiPc:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=SCZe3YABZNs:ft27q2XQiPc:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/SCZe3YABZNs